JP2010531312A5 - - Google Patents

Download PDF

Info

Publication number
JP2010531312A5
JP2010531312A5 JP2010513709A JP2010513709A JP2010531312A5 JP 2010531312 A5 JP2010531312 A5 JP 2010531312A5 JP 2010513709 A JP2010513709 A JP 2010513709A JP 2010513709 A JP2010513709 A JP 2010513709A JP 2010531312 A5 JP2010531312 A5 JP 2010531312A5
Authority
JP
Japan
Prior art keywords
bis
unsubstituted
pyridine
independently
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010513709A
Other languages
English (en)
Japanese (ja)
Other versions
JP5492769B2 (ja
JP2010531312A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/004638 external-priority patent/WO2009000412A1/en
Publication of JP2010531312A publication Critical patent/JP2010531312A/ja
Publication of JP2010531312A5 publication Critical patent/JP2010531312A5/ja
Application granted granted Critical
Publication of JP5492769B2 publication Critical patent/JP5492769B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010513709A 2007-06-26 2008-06-11 縮環されたベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的金属触媒合成 Expired - Fee Related JP5492769B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07290801 2007-06-26
EP07290801.5 2007-06-26
PCT/EP2008/004638 WO2009000412A1 (en) 2007-06-26 2008-06-11 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles

Publications (3)

Publication Number Publication Date
JP2010531312A JP2010531312A (ja) 2010-09-24
JP2010531312A5 true JP2010531312A5 (https=) 2011-07-07
JP5492769B2 JP5492769B2 (ja) 2014-05-14

Family

ID=39720505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010513709A Expired - Fee Related JP5492769B2 (ja) 2007-06-26 2008-06-11 縮環されたベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的金属触媒合成

Country Status (11)

Country Link
US (1) US20100216988A1 (https=)
EP (1) EP2173747B1 (https=)
JP (1) JP5492769B2 (https=)
KR (1) KR20100033484A (https=)
CN (1) CN101687865A (https=)
AT (1) ATE538120T1 (https=)
AU (1) AU2008267443A1 (https=)
BR (1) BRPI0813273A2 (https=)
CA (1) CA2693142A1 (https=)
IL (1) IL202822A0 (https=)
WO (1) WO2009000412A1 (https=)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9512125B2 (en) 2004-11-19 2016-12-06 The Regents Of The University Of California Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
WO2007114926A2 (en) 2006-04-04 2007-10-11 The Regents Of The University Of California Kinase antagonists
GB2467670B (en) 2007-10-04 2012-08-01 Intellikine Inc Chemical entities and therapeutic uses thereof
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
EP3613743B1 (en) 2008-01-04 2022-03-16 Intellikine, LLC Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
US8637542B2 (en) 2008-03-14 2014-01-28 Intellikine, Inc. Kinase inhibitors and methods of use
US8993580B2 (en) 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
JP5788316B2 (ja) 2008-07-08 2015-09-30 インテリカイン， エルエルシー キナーゼインヒビターおよび使用方法
US8703778B2 (en) 2008-09-26 2014-04-22 Intellikine Llc Heterocyclic kinase inhibitors
WO2010045542A2 (en) 2008-10-16 2010-04-22 The Regents Of The University Of California Fused ring heteroaryl kinase inhibitors
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
JP2010235575A (ja) * 2009-03-09 2010-10-21 Konica Minolta Holdings Inc 含窒素縮合複素環化合物の製造方法
EP2427195B1 (en) 2009-05-07 2019-05-01 Intellikine, LLC Heterocyclic compounds and uses thereof
CA2771609C (en) 2009-08-18 2018-10-02 Ventirx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
EP2467380B1 (en) 2009-08-18 2016-11-30 Ventirx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
CA2799579A1 (en) 2010-05-21 2011-11-24 Intellikine, Inc. Chemical compounds, compositions and methods for kinase modulation
TW201307347A (zh) 2010-11-01 2013-02-16 Arqule Inc 經取代苯並－咪唑並－吡啶並－二氮呯化合物
JP2013545749A (ja) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ， インコーポレイテッド 複素環化合物及びその使用
CN103313989B (zh) * 2010-12-16 2016-05-04 霍夫曼-拉罗奇有限公司 三环pi3k抑制剂化合物和使用方法
TWI674262B (zh) 2011-01-10 2019-10-11 美商英菲尼提製藥股份有限公司 製備異喹啉酮之方法及異喹啉酮之固體形式
US9295673B2 (en) 2011-02-23 2016-03-29 Intellikine Llc Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
MX2014000648A (es) 2011-07-19 2014-09-25 Infinity Pharmaceuticals Inc Compuestos heterociclicos y sus usos.
WO2013012915A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
KR20140075693A (ko) 2011-08-29 2014-06-19 인피니티 파마슈티칼스, 인코포레이티드 헤테로사이클릭 화합물 및 그의 용도
MX370814B (es) 2011-09-02 2020-01-08 Univ California Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
MX2015003874A (es) 2012-09-26 2015-12-16 Univ California Modulacion de ire1.
EP2914296B2 (en) 2012-11-01 2021-09-29 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2021012208A (es) 2013-10-04 2023-01-19 Infinity Pharmaceuticals Inc Compuestos heterocíclicos y usos de los mismos.
NZ724368A (en) 2014-03-19 2023-07-28 Infinity Pharmaceuticals Inc Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
CN105017257B (zh) * 2014-04-30 2017-05-24 华东理工大学 四氢茚并吡咯并咪唑的衍生物及其制备方法和用途
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR101540198B1 (ko) * 2015-01-29 2015-07-29 성균관대학교산학협력단 팔라듐이 함유된 카본 나이트라이드 지지체를 이용한 메탄올과 일산화탄소의 카르보닐레이션 반응으로부터 아세트산을 제조하기 위한 촉매 및 이의 제조방법
CN107635993B (zh) * 2015-03-18 2020-05-22 百时美施贵宝公司 取代的三环杂环化合物
EP4585268A3 (en) 2015-09-14 2025-10-15 Twelve Therapeutics, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
KR20180079328A (ko) * 2015-11-04 2018-07-10 이데미쓰 고산 가부시키가이샤 벤즈이미다졸 축합 헤테로아릴
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
CN105968044A (zh) * 2016-05-11 2016-09-28 张加明 一种乙氧基喹啉的工业化生产方法
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
RU2754507C2 (ru) 2016-06-24 2021-09-02 Инфинити Фармасьютикалз, Инк. Комбинированная терапия
CN110003213B (zh) * 2018-01-04 2021-10-08 南京农业大学 苯并咪唑并三嗪酮类化合物、制备方法及应用
CN111217819B (zh) * 2018-11-27 2021-05-14 杭州科巢生物科技有限公司 乌帕替尼的合成方法
WO2020227576A1 (en) * 2019-05-09 2020-11-12 Genentech, Inc. Regio-selective synthesis of imidazo[1,2-a]pyrimidines
CN110681362B (zh) * 2019-09-26 2020-09-11 浙江大学 以羧基和吲哚基为功能基团的混合模式层析介质
KR102698413B1 (ko) 2020-05-05 2024-08-26 뉴베일런트, 아이엔씨. 헤테로방향족 거대환식 에터 화학치료제
IL297832A (en) 2020-05-05 2023-01-01 Nuvalent Inc Macrocyclic heteroaromatic chemotherapeutic agents
CN112552305B (zh) * 2020-11-26 2021-11-30 广东省测试分析研究所（中国广州分析测试中心） 一种苯并环庚烷并咪唑并吡啶类阻燃抗紫外线分子材料及其制备方法与应用
CN113512068B (zh) * 2021-04-13 2022-05-31 山西大学 一种双配体的亚硝酰钌配合物及其制备方法和应用
US20230144528A1 (en) * 2021-09-30 2023-05-11 Prelude Therapeutics Incorporated CDK Inhibitors And Their Use As Pharmaceuticals
IL311444A (en) 2021-10-01 2024-05-01 Nuvalent Inc Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
CN114907421A (zh) * 2022-06-06 2022-08-16 河南师范大学 铑催化6-芳基嘌呤核苷和炔烃合成荧光多环嘌呤盐的方法
CN116943408B (zh) * 2023-06-30 2024-01-30 江苏创新石化有限公司 一种位阻胺复合脱硫剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049422A (en) * 1976-03-29 1977-09-20 United States Borax & Chemical Corporation Herbicidal morpholinobenzimidazoles
SU1587052A1 (ru) * 1988-06-27 1990-08-23 Всесоюзный научно-исследовательский институт химических средств защиты растений Способ получени 2,3-дигидро-1Н-пирроло [1,2- @ ]бензимидазол-6-сульфонамидов
US5583229A (en) * 1992-12-07 1996-12-10 Eisai Co., Ltd. Process for the preparation of imidazopyridine derivatives
JP2005519996A (ja) * 2001-10-18 2005-07-07 ミシガン ステイト ユニバーシティー オキサゾリジノン類の製造方法及びその使用方法
JP4999698B2 (ja) * 2004-11-29 2012-08-15 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病の治療または予防用のジペプチジルペプチダーゼ−ｉｖ阻害剤としての縮合アミノピペリジン

Similar Documents

Publication Publication Date Title
JP2010531312A5 (https=)
JP2010531313A5 (https=)
JP5492769B2 (ja) 縮環されたベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的金属触媒合成
Sawada et al. Discovery of the first non-peptide full agonists for the human bradykinin B2 receptor incorporating 4-(2-picolyloxy) quinoline and 1-(2-picolyl) benzimidazole frameworks
Yan et al. Aerobic synthesis of substituted quinoline from aldehyde and aniline: Copper-catalyzed intermolecular C–H active and C–C formative cyclization
Mcgill et al. Advances in the Chichibabin reaction
Newkome et al. Synthesis of 2, 2′‐Bipyridines: Versatile Building Blocks for Sexy Architectures and Functional Nanomaterials
EP1667982B1 (en) Isoquinolinone potassium channel inhibitors
JP5492770B2 (ja) ベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的銅触媒合成
Vessally et al. New page to access pyrazines and their ring fused analogues: Synthesis from N-propargylamines
Kannaboina et al. Recent advances in the global ring functionalization of 7-azaindoles
CN101010299A (zh) 用作丝氨酸蛋白酶抑制剂的6元杂环
IL203533A (en) Lactam-containing tetrahydro-pyrazolo [3,4-c] pyridine compounds useful as factor xa inhibitors and pharmaceutical compositions comprising the same for treating thromboembolic disorders
CN101679422A (zh) 作为受体酪氨酸激酶抑制剂的咪唑并[1,2-a]吡啶化合物
Devadoss et al. Synthesis of 1, 6‐naphthyridine and its derivatives: A systematic review
Khajuria et al. Recent developments in the synthesis of pyrido [1, 2-a] benzimidazoles
Hagui et al. Synthesis of 2, 2’‐Bipyridines through Catalytic C− C Bond Formations from C− H Bonds
Chen et al. Synthesis of N-biheteroarenes via acceptorless dehydrogenative coupling of benzocyclic amines with indole derivatives
Sunami et al. Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin
Schlosser et al. Nucleophilic substitutions of nitroarenes and pyridines: new insight and new applications
Chevallier et al. Lithiations and magnesiations on quinoline and isoquinoline
Shiri et al. Transition-metal-catalyzed reactions starting from 2, 3-substitutedquinoline derivatives
Fort et al. Lithiated Aza‐Heterocycles in Modern Synthesis
Raju et al. Deuteration of Six‐Membered N‐Heteroarenes: Chemistry and Applications
Liu et al. Rhodium (III)-Catalyzed Oxidative Annulation of 4-Aminoquinolines and Acrylate through Two Consecutive C (sp2)–H Activations